Lung Biopsy Systems Market Size, share to Grow at a CAGR of 9.80% between 2023 and 2030

NEW YORK - Jan. 17, 2024 - PRLog -- The latest market report published by Credence Research, Inc.  The global demand for Lung Biopsy Systems was valued at USD 2451.6 million in 2022 and is expected to reach USD 5179.2 Million in 2030, growing at a CAGR of 9.80% between 2023 and 2030.

Lung diseases, including lung cancer and various respiratory disorders, continue to be a significant global health concern. Timely and accurate diagnosis is crucial for effective treatment. Lung biopsy systems play a pivotal role in this process by providing healthcare professionals with tissue samples for analysis. As the world of healthcare continues to evolve, so too does the lung biopsy systems market. This article explores the current landscape and advancements in this field.

Market Overview

The global lung biopsy systems market has been experiencing steady growth due to the rising prevalence of lung diseases and an aging population. In 2022, the market was valued at approximately $1.3 billion, and it is expected to continue growing at a compound annual growth rate (CAGR) of around 6% between 2022 and 2027. This growth is fueled by technological advancements and innovations in lung biopsy procedures.

Technological Advancements

Minimally Invasive Techniques: Traditional open lung biopsies are invasive and carry a higher risk of complications. Minimally invasive techniques, such as video-assisted thoracoscopic surgery (VATS) and percutaneous needle biopsies, have gained popularity. These methods offer smaller incisions, reduced pain, and quicker recovery times for patients.

Imaging Guidance: The integration of advanced imaging technologies, such as CT scans and ultrasound, into lung biopsy systems has improved the accuracy of target identification. Real-time imaging allows healthcare professionals to precisely locate and target lesions or tumors, reducing the risk of complications and ensuring better diagnostic outcomes.

Browse the Full Report: https://www.credenceresearch.com/report/lung-biopsy-systems-market

List of Companies Covered:

• Cardinal Health Inc.
• Becton Dickinson and Company
• Olympus Corporation
• Argon Medical Devices Inc.
• Hologic Inc.
• Argon Medical Devices
• Fujifilm Medical Systems
• B. Braun Melsungen AG.
• DTR Medical
• Medtronic

By Segmentation

By Type of Lung Biopsy Procedure:

• Needle Biopsy
• Surgical Biopsy

By Guidance Method:

• CT-Guided Lung Biopsy
• Ultrasound-Guided Lung Biopsy
• Fluoroscopy-Guided Lung Biopsy
• Bronchoscopy

By End-User:

• Hospitals
• Diagnostic Laboratories
• Ambulatory Surgical Centers

By Indication:

• Lung Cancer
• Interstitial Lung Disease (ILD)
• Infection
• Other Lung Conditions

By Access Method:

• Percutaneous
• Transbronchial
• Open Surgical

By Product Type:

• Biopsy Needles
• Biopsy Guns
• Guidance Systems
• Accessories

By Product Type:

• High-End Lung Biopsy Systems
• Mid-Range Lung Biopsy Systems
• Economy Lung Biopsy Systems

By Region

• North America
• Europe
• Asia Pacific
• Rest of World